Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study
Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative S...
Saved in:
Published in | Gut Vol. 54; no. 10; pp. 1377 - 1383 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd and British Society of Gastroenterology
01.10.2005
BMJ Publishing Group LTD Copyright 2005 by Gut |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. |
---|---|
AbstractList | Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index [= or >, slanted]30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure.BACKGROUNDWe aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure.In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation.METHODSIn a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation.The prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)).RESULTSThe prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)).GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.CONCLUSIONSGORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. The prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity. |
Author | Ronkainen, J Storskrubb, T Aro, P Bolling-Sternevald, E Agréus, L Talley, N J |
AuthorAffiliation | 3 Astra Zeneca R&D, Mölndal, Sweden 1 Centre for Family Medicine, Karolinska Institiutet, Stockholm, Sweden 2 Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic College of Medicine, Rochester, MN, and Department of Medicine, University of Sydney and Nepean Hospital, Sydney, Australia |
AuthorAffiliation_xml | – name: 3 Astra Zeneca R&D, Mölndal, Sweden – name: 2 Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic College of Medicine, Rochester, MN, and Department of Medicine, University of Sydney and Nepean Hospital, Sydney, Australia – name: 1 Centre for Family Medicine, Karolinska Institiutet, Stockholm, Sweden |
Author_xml | – sequence: 1 givenname: P surname: Aro fullname: Aro, P organization: Astra Zeneca R&D, Mölndal, Sweden – sequence: 2 givenname: J surname: Ronkainen fullname: Ronkainen, J organization: Astra Zeneca R&D, Mölndal, Sweden – sequence: 3 givenname: N J surname: Talley fullname: Talley, N J organization: Astra Zeneca R&D, Mölndal, Sweden – sequence: 4 givenname: T surname: Storskrubb fullname: Storskrubb, T organization: Astra Zeneca R&D, Mölndal, Sweden – sequence: 5 givenname: E surname: Bolling-Sternevald fullname: Bolling-Sternevald, E organization: Astra Zeneca R&D, Mölndal, Sweden – sequence: 6 givenname: L surname: Agréus fullname: Agréus, L organization: Astra Zeneca R&D, Mölndal, Sweden |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15917313$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:1958942$$DView record from Swedish Publication Index |
BookMark | eNqFks1v1DAQxS1URLeFMzcUCYkDUrZ2HMcxh0qw4ktaARIFJC6WE0-23iZ2iB3Y_e9xyFJoD3By5Pm98cubOUFH1llA6CHBS0JocbYZwzLDOF9ixnPB76AFyYsypVlZHqEFxoSnU-EYnXi_xRiXpSD30DFhgnBK6AJ1L5zeJ53yPjFWwy5RVif15eCsqZPRwq5vlbGgk43yYXDGBvDBWNUmft_1wXX-WZQkSo9tSMBq52vXR2nv-rFVwTibVMpHvQ-j3t9HdxvVenhwOE_Rp1cvL1Zv0vX7129Xz9dpxUQR0hw3jcANADABuSgyWgqR6wzzYjLOgWgsMAHKi4KQHDNdYc4b3GgGKpL0FKVzX_8D-rGS_WA6NeylU0Yerq7iF0hW4oKVkT-f-VjpQNdgw6DaG7KbFWsu5cZ9l9FMzHtq8OTQYHDfxhiR7IyvoW2VBTd6WZSMi5JOzh7fArduHGKefuolaBwKppF69LefayO_5xaBsxmoB-f9AM0fBMtpM2TcDDlthpw3IyrYLUVtwq8BxR8y7T90hyiND7C7fkYNV7LglDP57vNKri-yL-TrRy4_RP7pzFfd9r-mfgIfA9wD |
CODEN | GUTTAK |
CitedBy_id | crossref_primary_10_1111_nmo_70017 crossref_primary_10_1186_s12876_022_02531_3 crossref_primary_10_1097_MEG_0b013e328332f7b8 crossref_primary_10_1111_j_1440_1746_2011_07042_x crossref_primary_10_1002_edm2_70041 crossref_primary_10_1108_00346650810920141 crossref_primary_10_3346_jkms_2010_25_9_1318 crossref_primary_10_1038_s41430_022_01108_3 crossref_primary_10_1111_joim_13148 crossref_primary_10_14341_omet12706 crossref_primary_10_1007_s11377_006_0059_0 crossref_primary_10_1007_s00101_011_1922_z crossref_primary_10_1007_s42000_019_00113_9 crossref_primary_10_1016_j_cgh_2007_05_015 crossref_primary_10_1038_ijo_2010_245 crossref_primary_10_1113_EP085427 crossref_primary_10_1111_apt_15500 crossref_primary_10_1185_03007990903080931 crossref_primary_10_1177_1756283X14538689 crossref_primary_10_1007_s11695_008_9462_6 crossref_primary_10_3389_fped_2023_1241801 crossref_primary_10_1053_j_gastro_2007_01_047 crossref_primary_10_1038_s41430_018_0109_y crossref_primary_10_1586_17474124_2_1_93 crossref_primary_10_14309_ajg_0000000000002400 crossref_primary_10_4166_kjg_2012_59_1_1 crossref_primary_10_1097_MEG_0b013e3282f246a2 crossref_primary_10_1016_j_ejphar_2024_176881 crossref_primary_10_14309_00000434_200612001_00009 crossref_primary_10_1016_j_gtc_2009_12_007 crossref_primary_10_1111_nmo_13549 crossref_primary_10_1111_obr_13673 crossref_primary_10_3390_nu14194157 crossref_primary_10_26442_00403660_2021_08_200983 crossref_primary_10_1038_s41598_022_23098_9 crossref_primary_10_1016_j_nut_2019_02_004 crossref_primary_10_1186_s12937_019_0487_6 crossref_primary_10_1016_j_gcb_2008_12_008 crossref_primary_10_5056_jnm14124 crossref_primary_10_1038_s41575_021_00487_5 crossref_primary_10_1016_j_gastrohep_2016_08_001 crossref_primary_10_1007_s10620_008_0411_y crossref_primary_10_4103_ejim_ejim_42_17 crossref_primary_10_3746_pnf_2021_26_2_146 crossref_primary_10_1016_j_obpill_2023_100055 crossref_primary_10_1111_j_1467_789X_2011_00969_x crossref_primary_10_1186_s40608_018_0206_4 crossref_primary_10_1111_j_1572_0241_2006_01015_x crossref_primary_10_1016_S0739_5930_08_70264_2 crossref_primary_10_1007_s11695_024_07080_0 crossref_primary_10_1016_j_ajcnut_2025_03_001 crossref_primary_10_1111_j_1365_2036_2009_04021_x crossref_primary_10_1039_D3EN00650F crossref_primary_10_1186_s12944_025_02451_7 crossref_primary_10_1002_jgh3_12757 crossref_primary_10_26442_20751753_2022_5_201730 crossref_primary_10_1590_S0004_28032009000100008 crossref_primary_10_4082_kjfm_2010_31_1_44 crossref_primary_10_5056_jnm_2010_16_3_291 crossref_primary_10_1002_ueg2_12334 crossref_primary_10_1097_01_mcg_0000225631_07039_6d crossref_primary_10_1053_j_gastro_2016_12_052 crossref_primary_10_1016_j_amjmed_2012_08_017 crossref_primary_10_1016_j_gastre_2017_05_005 crossref_primary_10_1038_s41598_024_66869_2 crossref_primary_10_1186_s12889_023_16543_5 crossref_primary_10_1007_s11605_007_0294_9 crossref_primary_10_1111_j_1572_0241_2007_01342_x crossref_primary_10_3748_wjg_v23_i26_4689 crossref_primary_10_1016_j_orcp_2015_05_018 crossref_primary_10_17116_dokgastro20211002152 crossref_primary_10_5056_jnm_2010_16_1_8 crossref_primary_10_1097_MEG_0b013e32832a7d87 crossref_primary_10_4254_wjh_v13_i12_1816 crossref_primary_10_1007_s00535_015_1111_y crossref_primary_10_1016_j_cgh_2014_03_021 crossref_primary_10_1053_j_gastro_2006_02_048 crossref_primary_10_1097_MCG_0000000000000364 crossref_primary_10_1016_j_gastha_2022_07_019 crossref_primary_10_1007_s11695_016_2100_9 crossref_primary_10_1016_j_diabet_2015_11_006 crossref_primary_10_1097_CM9_0000000000002147 crossref_primary_10_1185_030079906X89748 crossref_primary_10_1371_journal_pone_0123993 crossref_primary_10_3390_biomedicines12081854 crossref_primary_10_3904_kjm_2019_94_5_425 crossref_primary_10_3164_jcbn_22_143 crossref_primary_10_1016_j_soard_2014_09_004 crossref_primary_10_1002_ibd_21801 crossref_primary_10_1111_jgh_13146 crossref_primary_10_1186_s12876_017_0650_5 |
ContentType | Journal Article |
Copyright | Copyright 2005 by Gut Copyright: 2005 Copyright 2005 by Gut Copyright © Copyright 2005 by Gut 2005 |
Copyright_xml | – notice: Copyright 2005 by Gut – notice: Copyright: 2005 Copyright 2005 by Gut – notice: Copyright © Copyright 2005 by Gut 2005 |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM ADTPV AOWAS |
DOI | 10.1136/gut.2004.057497 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3288 1458-3288 |
EndPage | 1383 |
ExternalDocumentID | oai_swepub_ki_se_580658 PMC1774688 4014125611 15917313 10_1136_gut_2004_057497 ark_67375_NVC_LT2W1ZS7_P gutjnl |
Genre | Journal Article |
GeographicLocations | Sweden United States--US |
GeographicLocations_xml | – name: Sweden – name: United States--US |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 18M 29I 2WC 354 39C 3O- 4.4 40O 53G 5GY 5VS 7X7 7~S 88E 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAUVZ AAWJN AAYEP ABAAH ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AI. AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 DWQXO E3Z EBS EJD F5P FD8 FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR INH INR IOF ITC J5H KQ8 L7B LK8 M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VH1 VM9 VVN W8F WH7 WOQ X7M YFH YOC YQY ZGI ZXP ZY1 3V. ABJNI BSCLL RHF AAYXX ACQHZ ADGHP AERUA CITATION PHGZM CGR CUY CVF ECM EIF NPM PKN 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM ADTPV AOWAS PUEGO |
ID | FETCH-LOGICAL-b596t-40ff90feee59e496238994d207659177e1d0901e376611405db077f0fd5ea9943 |
IEDL.DBID | 7X7 |
ISSN | 0017-5749 |
IngestDate | Mon Aug 25 03:40:48 EDT 2025 Thu Aug 21 13:49:41 EDT 2025 Fri Jul 11 05:07:08 EDT 2025 Fri Jul 25 11:10:42 EDT 2025 Wed Feb 19 01:40:23 EST 2025 Thu Apr 24 22:57:54 EDT 2025 Tue Jul 01 04:11:14 EDT 2025 Wed Oct 30 09:39:13 EDT 2024 Thu Apr 24 23:05:35 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b596t-40ff90feee59e496238994d207659177e1d0901e376611405db077f0fd5ea9943 |
Notes | istex:220CF6A2CC4FC4BA1F27B94F4CBEE5EDD056A882 href:gutjnl-54-1377.pdf PMID:15917313 Correspondence to: Professor N J Talley Mayo Clinic College of Medicine, Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic, 200 First St, PL-6-56, Rochester, MN 55905, USA; talley.nicholas@mayo.edu ark:/67375/NVC-LT2W1ZS7-P local:0541377 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Correspondence to: Professor N J Talley Mayo Clinic College of Medicine, Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic, 200 First St, PL-6-56, Rochester, MN 55905, USA; talley.nicholas@mayo.edu Published online first 25 May 2005 |
OpenAccessLink | https://gut.bmj.com/content/gutjnl/54/10/1377.full.pdf |
PMID | 15917313 |
PQID | 1779331303 |
PQPubID | 2041069 |
PageCount | 7 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_580658 pubmedcentral_primary_oai_pubmedcentral_nih_gov_1774688 proquest_miscellaneous_68579834 proquest_journals_1779331303 pubmed_primary_15917313 crossref_primary_10_1136_gut_2004_057497 crossref_citationtrail_10_1136_gut_2004_057497 istex_primary_ark_67375_NVC_LT2W1ZS7_P bmj_primary_10_1136_gut_2004_057497 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-10-01 |
PublicationDateYYYYMMDD | 2005-10-01 |
PublicationDate_xml | – month: 10 year: 2005 text: 2005-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Gut |
PublicationTitleAlternate | Gut |
PublicationYear | 2005 |
Publisher | BMJ Publishing Group Ltd and British Society of Gastroenterology BMJ Publishing Group LTD Copyright 2005 by Gut |
Publisher_xml | – name: BMJ Publishing Group Ltd and British Society of Gastroenterology – name: BMJ Publishing Group LTD – name: Copyright 2005 by Gut |
References | 8122651 - Am J Gastroenterol. 1994 Mar;89(3):387-91 6288509 - Gastroenterology. 1982 Nov;83(5):963-9 15339321 - Aliment Pharmacol Ther. 2004 Sep 1;20(5):497-505 10548135 - J Clin Psychiatry. 1999;60 Suppl 21:5-9 14687160 - Am J Gastroenterol. 2004 Jan;99(1):170-81 3237852 - Physiol Behav. 1988;44(4-5):665-8 15012771 - J Gastroenterol Hepatol. 2004 Apr;19(4):357-67 15051594 - Am J Clin Nutr. 2004 Apr;79(4):537-43 15305996 - Neurogastroenterol Motil. 2004 Aug;16(4):413-9 984016 - Am J Dig Dis. 1976 Nov;21(11):953-6 8389339 - Int J Obes Relat Metab Disord. 1993 May;17(5):295-300 15181019 - J Clin Endocrinol Metab. 2004 Jun;89(6):2522-5 12837713 - JAMA. 2003 Jul 2;290(1):66-72 10861260 - Gut. 2000 Jul;47(1):26-9 9136821 - Gastroenterology. 1997 May;112(5):1448-56 8146509 - Scand J Prim Health Care. 1993 Dec;11(4):252-62 10906830 - Ann Intern Med. 2000 Aug 1;133(3):165-75 1967675 - Lancet. 1990 Jan 27;335(8683):205-8 10378622 - Am J Med. 1999 Jun;106(6):642-9 10720111 - Scand J Gastroenterol. 2000 Feb;35(2):142-51 9659166 - Gut. 1998 May;42(5):690-5 12913045 - Int J Epidemiol. 2003 Aug;32(4):645-50 9829354 - Scand J Gastroenterol. 1998 Oct;33(10):1023-9 12126237 - Scand J Gastroenterol. 2002 Jun;37(6):626-30 3414573 - Am J Clin Nutr. 1988 Sep;48(3):592-4 7657095 - Gastroenterology. 1995 Sep;109(3):671-80 12181383 - Obes Res. 2002 Aug;10(8):748-56 7395839 - Am J Gastroenterol. 1980 Feb;73(2):127-30 15089906 - Am J Gastroenterol. 2004 Apr;99(4):711-8 10638576 - Am J Gastroenterol. 2000 Jan;95(1):157-65 15330923 - Am J Gastroenterol. 2004 Sep;99(9):1807-14 2338264 - Gut. 1990 Apr;31(4):401-5 12365955 - JAMA. 2002 Oct 9;288(14):1723-7 15229334 - Obes Res. 2004 Jun;12(6):949-55 15330922 - Am J Gastroenterol. 2004 Sep;99(9):1801-6 663647 - Science. 1978 Jul 14;201(4351):165-7 11693325 - Am J Gastroenterol. 2001 Oct;96(10):2905-14 15104363 - Dig Dis Sci. 2004 Feb;49(2):237-42 8793471 - Eur Respir J. 1996 May;9(5):1073-8 15113714 - Am J Clin Nutr. 2004 May;79(5):774-9 15743007 - Scand J Gastroenterol. 2004 Dec;39(12):1280-8 1804576 - Dig Dis. 1991;9(6):360-4 3116071 - J Clin Gastroenterol. 1987 Aug;9(4):386-9 15932168 - Scand J Gastroenterol. 2005 Mar;40(3):275-85 10501410 - Ann Epidemiol. 1999 Oct;9(7):424-35 14647184 - Int J Obes Relat Metab Disord. 2004 Feb;28(2):254-61 15199035 - JAMA. 2004 Jun 16;291(23):2847-50 7714465 - J Intern Med. 1995 Apr;237(4):411-8 15086867 - Neurogastroenterol Motil. 2004 Apr;16(2):135-42 |
References_xml | – reference: 15089906 - Am J Gastroenterol. 2004 Apr;99(4):711-8 – reference: 10378622 - Am J Med. 1999 Jun;106(6):642-9 – reference: 14687160 - Am J Gastroenterol. 2004 Jan;99(1):170-81 – reference: 15199035 - JAMA. 2004 Jun 16;291(23):2847-50 – reference: 12181383 - Obes Res. 2002 Aug;10(8):748-56 – reference: 15104363 - Dig Dis Sci. 2004 Feb;49(2):237-42 – reference: 7714465 - J Intern Med. 1995 Apr;237(4):411-8 – reference: 3237852 - Physiol Behav. 1988;44(4-5):665-8 – reference: 3414573 - Am J Clin Nutr. 1988 Sep;48(3):592-4 – reference: 14647184 - Int J Obes Relat Metab Disord. 2004 Feb;28(2):254-61 – reference: 2338264 - Gut. 1990 Apr;31(4):401-5 – reference: 15051594 - Am J Clin Nutr. 2004 Apr;79(4):537-43 – reference: 15743007 - Scand J Gastroenterol. 2004 Dec;39(12):1280-8 – reference: 8146509 - Scand J Prim Health Care. 1993 Dec;11(4):252-62 – reference: 15012771 - J Gastroenterol Hepatol. 2004 Apr;19(4):357-67 – reference: 8389339 - Int J Obes Relat Metab Disord. 1993 May;17(5):295-300 – reference: 12365955 - JAMA. 2002 Oct 9;288(14):1723-7 – reference: 7657095 - Gastroenterology. 1995 Sep;109(3):671-80 – reference: 9136821 - Gastroenterology. 1997 May;112(5):1448-56 – reference: 15229334 - Obes Res. 2004 Jun;12(6):949-55 – reference: 984016 - Am J Dig Dis. 1976 Nov;21(11):953-6 – reference: 6288509 - Gastroenterology. 1982 Nov;83(5):963-9 – reference: 9659166 - Gut. 1998 May;42(5):690-5 – reference: 8793471 - Eur Respir J. 1996 May;9(5):1073-8 – reference: 10501410 - Ann Epidemiol. 1999 Oct;9(7):424-35 – reference: 9829354 - Scand J Gastroenterol. 1998 Oct;33(10):1023-9 – reference: 7395839 - Am J Gastroenterol. 1980 Feb;73(2):127-30 – reference: 10906830 - Ann Intern Med. 2000 Aug 1;133(3):165-75 – reference: 10638576 - Am J Gastroenterol. 2000 Jan;95(1):157-65 – reference: 12126237 - Scand J Gastroenterol. 2002 Jun;37(6):626-30 – reference: 663647 - Science. 1978 Jul 14;201(4351):165-7 – reference: 15330922 - Am J Gastroenterol. 2004 Sep;99(9):1801-6 – reference: 11693325 - Am J Gastroenterol. 2001 Oct;96(10):2905-14 – reference: 8122651 - Am J Gastroenterol. 1994 Mar;89(3):387-91 – reference: 15339321 - Aliment Pharmacol Ther. 2004 Sep 1;20(5):497-505 – reference: 1804576 - Dig Dis. 1991;9(6):360-4 – reference: 12837713 - JAMA. 2003 Jul 2;290(1):66-72 – reference: 15113714 - Am J Clin Nutr. 2004 May;79(5):774-9 – reference: 15181019 - J Clin Endocrinol Metab. 2004 Jun;89(6):2522-5 – reference: 15086867 - Neurogastroenterol Motil. 2004 Apr;16(2):135-42 – reference: 10861260 - Gut. 2000 Jul;47(1):26-9 – reference: 15330923 - Am J Gastroenterol. 2004 Sep;99(9):1807-14 – reference: 15932168 - Scand J Gastroenterol. 2005 Mar;40(3):275-85 – reference: 1967675 - Lancet. 1990 Jan 27;335(8683):205-8 – reference: 15305996 - Neurogastroenterol Motil. 2004 Aug;16(4):413-9 – reference: 10548135 - J Clin Psychiatry. 1999;60 Suppl 21:5-9 – reference: 3116071 - J Clin Gastroenterol. 1987 Aug;9(4):386-9 – reference: 12913045 - Int J Epidemiol. 2003 Aug;32(4):645-50 – reference: 10720111 - Scand J Gastroenterol. 2000 Feb;35(2):142-51 |
SSID | ssj0008891 |
Score | 2.16079 |
Snippet | Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to... We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this... Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to... |
SourceID | swepub pubmedcentral proquest pubmed crossref istex bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1377 |
SubjectTerms | Abdomen abdominal symptom questionnaire Antacids - therapeutic use ASQ BMI Body Mass Index Chronic Disease Cohort Studies dyspepsia Endoscopy, Gastrointestinal - methods epidemiology Esophageal Sphincter, Lower - drug effects Esophageal Sphincter, Lower - physiopathology Esophagitis - complications Esophagitis - epidemiology Female gastro-oesophageal reflux disease gastro-oesophageal reflux symptoms Gastroesophageal reflux Gastroesophageal Reflux - epidemiology Gastroesophageal Reflux - etiology Gastroesophageal Reflux - physiopathology gastrointestinal symptoms GORD GORS Humans IBS identity number irritable bowel syndrome LOS lower oesophageal sphincter Male Middle Aged obesity Obesity - complications Obesity - epidemiology Obesity - physiopathology odds ratio OEG oesophagogastroduodenoscopy population study Population Surveillance - methods Population-based studies Pressure Prevalence questionnaires Sweden - epidemiology |
Title | Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study |
URI | http://gut.bmj.com/content/54/10/1377.full https://api.istex.fr/ark:/67375/NVC-LT2W1ZS7-P/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/15917313 https://www.proquest.com/docview/1779331303 https://www.proquest.com/docview/68579834 https://pubmed.ncbi.nlm.nih.gov/PMC1774688 http://kipublications.ki.se/Default.aspx?queryparsed=id:1958942 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Zb9QwELagKyFeEDeBUiyBEC9pk40dO7wgWlqVo6sKWljxYiVru0Cbg01Wav89M85RRVxvSexxLM94jnjyDSHPUsaTFPjuc2mlz6zRvgQz4GvJsHyctpnG_50PZvH-MXs35_Pug1vdpVX2OtEpal0u8Bv5VihgxAg17qvqp49Vo_B0tSuhcZVMELoMU7rEfAi4MIMn7DUxFyzpoH3CKN46WblESrYZYAPapiz_MbJNE1zm8z85nr_nT45QRp1l2rtJbnQuJX3dysAtcsUUt8m1g-7Q_A7Jt0t9QXPwkqnDRqRpoemiBcWlq8KcV2cpdNT0JK2bZYkAErDvccj6Iq-aMq9fAgl1SB3UFLrEP1mAtBpqf1G0hZo6qNq75Hhv92hn3--qLPgZT-IGAkhrk8AaY3hiWALuEIRgTE8DEXOI5YQJdQBOgwFNFEPwFHCdBULYwGpuUugZ3SNrRVmYB4QyE5lY2qk1VsNIMuNTk2VWJwtroshyjzyFVVZVi6OhXPwRxQp4gdUwmWp54ZHNngtq0QGVY72Ms78TvBgI_jv2c8fWoV-6PMXUNsHV7POO-nA0_RJ-_STUoUfWe76rblfX6lIGPfJkaIb9iIcsaWHKVa1iyUUiI-aR-62QXE4JlxOoPSJG4jN0QKTvcUvx_ZtD_IYXs1hKmH0raCOS7tEpXBnF8aBcPvz37B-R6z0CbRCuk7VmuTKPwbdqsg23gTbIZHt3dvgR7t68ff8L7iAmVw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NVgJeEN8LDGaJD_GSLU3sxEFCiI1NHWurCTqYePGS2h6wNQlNK9Z_ir-Rc76miK-nvUW172Lld77z1fbvAJ5GlIUR4m4zrrlNtZI2xzBgS05N-TipY2nuOw9Hfv-QvjtiRyvws74LY45V1j6xcNQynZj_yDd7AWr0jMd9nX23TdUos7tal9AozWJfLX9gypa_2nuL-D5z3d2d8XbfrqoK2DEL_TkmTFqHjlZKsVDREMM_phxUupjQM8xdAtWTDgZJhTPPx2TBYTJ2gkA7WjIVYU8P9V6BLvUwlelAd2tndPC-8f28rtGHvp8FNKzIhHqev3myKI5u0g3HNJhoGE-_taJh1wB7_qel7u8nNlu8pkUs3L0JN6pFLHlTWt0tWFHJbbg6rLbp78B0K5VLMsV1OSnYGEmUSDIpaXjJIlHn2VmEHSU5ifL5LDWUFehpjMp8Oc3m6TR_iSKk4AYhKpGpuTuDollTbYyY6CtJQY57Fw4vBYF70EnSRK0CocpTPteuVlqiJh4zV8WxluFEK8_TzIIn-JVFVjJ3iCLj8XyBWJj6m1SUWFiwUaMgJhU1uqnQcfZ3gReNwH91Py9gbfpFs1NzmC5gYvRxWwzG7qfe5w-BOLBgrcZdVH4kFxdWb8F604wewGzrRIlKF7nwOQtC7lEL7pdGcjEk8zlR2oKgZT5NB8Mt3m5Jvn4pOMbxxdTnHEdfGlpLpPrpFJ-UYGZrnj_49-jX4Vp_PByIwd5o_yFcr_lvnd4adOazhXqEK7t5_LiaTgSOL3sG_wIHV1_Z |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKK1W8IG4WCrXEIV622cNee5EQgpaopW1UiRYiXsxubLelze6STUTz1_h1zOxVRVxPfYtiz8TyXJ54_A0hzxLG4wTk7nJppcus0a6EMOBqybB9nLapxvfO-4No-4h9GPLhEvnZvoXBssrWJ1aOWucj_I-85wvgGKLH7dmmLOJgq_-m-O5iBym8aW3badQqsmvmPyB9K1_vbIGsnwdB__3h5rbbdBhwUx5HU0ierI09a4zhsWExHAUg_WA6gOSeQx4jjK89CJgGrDCCxMHjOvWEsJ7V3CQwMwS-18iKCLmPNiaGXbKH1UN-GwW4YHEDK-SHUe94VhVxsg0PBzAupuNvC3FxBUV88adD7--1mwsIp1VU7N8kN5rjLH1b698tsmSy22R1v7mwv0PG73I9p2M4odMKl5EmmaajGpCXzjJzUZwnMFHT46ScTnIErwCfgyzL-biY5uPyFZDQCiWEmkzn-IoGSIuu7xjFOKxpBZN7lxxdyf7fI8tZnpkHhDITmkjawBqrgZNMeWDS1Op4ZE0YWu6Qp7DLqqgxPFSV-4SRAllgJ06malk4ZKOVgho1IOnYq-P87wQvO4L_8n5RibWbl0zOsKxOcDX4tKn2DoPP_pePQh04ZK2Vu2o8Sqku9d8h690w-AK84Ekyk89KFUkuYhkyh9yvleRySbidQO0QsaA-3QREGV8cyU5PKrRx-GEWSQmrrxVtgaT56gw-GcXxkl4-_Pfq18kq2K3a2xnsPiLXWyBcz18jy9PJzDyGI940fVLZEiVfr9p4fwGDBWKp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Body+mass+index+and+chronic+unexplained+gastrointestinal+symptoms%3A+an+adult+endoscopic+population+based+study&rft.jtitle=Gut&rft.au=Aro%2C+P&rft.au=Ronkainen%2C+J&rft.au=Talley%2C+N+J&rft.au=Storskrubb%2C+T&rft.date=2005-10-01&rft.issn=0017-5749&rft.volume=54&rft.issue=10&rft.spage=1377&rft_id=info:doi/10.1136%2Fgut.2004.057497&rft_id=info%3Apmid%2F15917313&rft.externalDocID=15917313 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon |